KYMR — KYMERA THERAPEUTICS INC

Ownership history in Caption Management, LLC  ·  9 quarters on record

This page tracks every 13F SEC filing in which Caption Management, LLC reported a position in KYMERA THERAPEUTICS INC (KYMR). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.17% (2022 Q4)
Avg. % of fund
0.06%
First filed
2022 Q1
Last filed
2025 Q3
Quarters held
9
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 18,600 +4,100 +28.3% 0.01% $1.1M $56.60
2025 Q2 REDUCED 14,500 -7,100 -32.9% 0.01% $633K $43.64
2025 Q2 REDUCED 21,600 -43,200 -66.7% 0.01% $943K $43.64
2025 Q2 ADDED 64,800 +29,600 +84.1% 0.03% $2.8M $43.64
5 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    KYMR price (monthly, adj. close)

Other funds also holding KYMR

As of 2025 Q4 — sorted by position size

Atlas Venture Life Science Advisors, LLC 3Y 41.91% BVF INC/IL 3Y 7Y 14.41% Siren, L.L.C. 7.63% Avoro Capital Advisors LLC 3Y 7Y 5.72% Octagon Capital Advisors LP 3Y 5.05% Monashee Investment Management LLC 3Y 7Y 4.38% BAKER BROS. ADVISORS LP 3Y 7Y 3.94% Commodore Capital LP 3Y 3.88% Eagle Health Investments LP 3Y 2.33% Patient Square Capital LP 3Y 2.32%
← Back to Caption Management, LLC Holdings